Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy

American Journal of Human Genetics

Volumn 63, Issue 6, 1998, Pages 1578-1587

  Engelman, Jeffrey A ^a   Zhang, Xiaolan ^a   Galbiati, Ferruccio ^a   Volonté, Daniela ^a   Sotgia, Federica ^a   Pestell, Richard G ^a   Minetti, Carlo ^c   Scherer, Philipp E ^b   Okamoto, Takashi ^d   Lisanti, Michael P ^a,b  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF GENOA   (Italy)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN;

ALZHEIMER DISEASE; CANCER GENETICS; DIABETES MELLITUS; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC LINKAGE; HUMAN; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW;

EID: 0032471541     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302172     Document Type: Article

References (49)

1. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP (1997a) Identification of peptide and protein ligands for the caveolinscaffolding domain: implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272: 6525-6533
2. Couet J, Li S, Okamoto T, Scherer PS, Lisanti MP (1997b) Molecular and cellular biology of caveolae: paradoxes and plasticities. Trends Cardiovasc Med 7:103-110
3. Couet J, Sargiacomo M, Lisanti MP (1997c) Interaction of a receptor tyrosine kinase, EGF-R, with caveolins: caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272:30429-30438
4. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, et al. (1998a) Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo: a role for the caveolin-scaffolding domain. FEBS Lett 428:205-211
5. Engelman JA, Lee RJ, Karnezis A, Bearss DJ, Webster M, Siegel P, Muller WJ, et al. (1998b) Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo: implications for human breast cancer. J Biol Chem 273:20448-20455
6. Engelman JA, Wycoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP (1997) Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 272:16374-16381
7. Engelman JA, Zhang XL, Galbiati F, Lisanti MP (1998c) Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1,-2, and-3): Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett 429:330-336
8. Engelman JA, Zhang XL, Lisanti MP (1998d) Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett 436:403-410
9. Faux M, Scott J (1996) Molecular glue: kinase anchoring and scaffold proteins. Cell 85:9-12
10. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell R, Lisanti MP (1998a) Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17: 6633-6648
11. Galbiati F, Volonté D, Gil O, Zanazzi G, Salzer JL, Sargiacomo M, Scherer PE, et al. (1998b) Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is upregulated in response to cell injury. Proc Natl Acad Sci USA 95:10257-10262
12. Garcia-Cardena G, Martasek P, Siler-Masters BS, Skidd PM, Couet JC, Li S, Lisanti MP, et al (1997) Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 272:25437-25440
13. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM (1989) Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 339:155-156
14. Glenney JR (1992) The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Lett 314:45-48
15. Ikezu T, Trapp BD, Song KS, Schegel A, Lisanti MP, Okamoto T (1998) Caveolae, plasma membrane micro-domains for a-secretase-mediated processing of the amyloid precursor protein (APP). J Biol Chem 273:10485-10495
16. Ikezu T, Ueda H, Trapp BD, Nishiyama K, Sha JF, Volonté D, Galbiati F, et al. (1998) Affinity-purification and characterization of caveolins from the brain. Differential expression of caveolin-1, -2 and -3 in brain endothelial and astroglial cell types. Brain Res 804:177-192
17. Koleske AJ, Baltimore D, Lisanti MP (1995) Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92:1381-1385
18. Lee SJ, Liyanage U, Bickel PE, Xia W, Lansbury PT, Kosik KS (1998a) A detergent-insoluble membrane compartment contains A-beta in vivo. Nat Med 4:730-734
19. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE (1998b) Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16:1391-1397
20. Li S, Couet J, Lisanti MP (1996a) Src tyrosine kinases, G alpha subunits and H-Ras share a common membrane-anchored scaffolding protein, caveolin: caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271:29182-29190
21. Li S, Galbiati F, Volonté D, Sargiacomo M, Engelman JA, Das K, Scherer PE, et al. (1998) Mutational analysis of caveolin-induced vesicle formation: expression of caveolin-1 recruits caveolin-2 to caveolae membranes, FEBS Lett 434:127-134
22. Li S, Song KS, Koh SS, Kikuchi A, Lisanti MP (1996b) Baculovirus-based expression of mammalian caveolin in Sf21 insect cells: a model system for the biochemical and morphological study of caveolar biogenesis. J Biol Chem 271: 28647-28654
23. Lisanti MP, Scherer P, Tang ZL, Sargiacomo M (1994a) Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol 4:231-235
24. Lisanti MP, Scherer PE, Vidugiriene J, Tang ZL, Hermanoski- Vosatka A, Tu YH, Cook RF, et al (1994b) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126:111-126
25. Liu J, Oh P, Homer T, Rogers RA, Schnitzer JE (1997a) Organized endothelial cell signal transduction in caveolae. J Biol Chem 272:7211-7222
26. Liu P, Ying YS, Anderson RGW (1997k) PDGF activates MAP kinase in isolated caveolae. Proc Natl Acad Sci USA 94: 13666-13670
27. McNally EM, de Sá Moreira E, Duggan DJ, Bönnemann CG, Lisanti MP, Lidov HGW, Vainzof M, et al. (1998) Caveolin-3 in muscular dystrophy. Hum Mol Genet 7:871-877
28. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, et al. (1998) Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 18:365-368
29. Oka N, Yamamoto M, Schwencke C, Kawabe J, Ebina T, Couet J, Lisanti MP, et al. (1997) Caveolin interaction with protein kinase C: isoenzyme-dependent regulation of kinase activity by the caveolin-scaffolding domain peptide. J Biol Chem 272:33416-33421
30. Okamoto T, Schlegel A, Scherer PE, Lisanti MP (1998) Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422
31. Parton RG (1996) Caveolae and caveolins. Curr Opin Cell Biol 8:542-548
32. Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, Chung LW (1995) c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 154: 293-298
33. Rubin CS (1994) A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochim Biophys Acta 1224:467-479
34. Sager R, Sheng S, Anisowicz A, Sotiropoulou G, Zou Z, Stenman G, Swisshelm K, et al. (1994) RNA Genetics of breast cancer: maspin as a paradigm. Cold Spring Harb Symp Quant Biol 59:537-546
35. Sargiacomo M, Scherer PE, Tang ZL, Kubler E, Song KS, Sanders MC, Lisanti MP (1995) Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci USA 92:9407-9411
36. Sargiacomo M, Sudol M, Tang ZL, Lisanti MP (1993) Signal transducing molecules and GPI-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122: 789-807
37. Scherer PE, Lewis RY, Volonté D, Engelman JA, Galbiati F, Couet J, Kohtz DS, et al. (1997a) Cell-type and tissue-specific expression of caveolin-2: caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272:29337-29346
38. Scherer PE, Lisanti MP (1997b) Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes: dynamic regulation by extra-cellular glucose and intracellular metabolites. J Biol Chem 272:20698-20705
39. Scherer P, Lisanti MP, Baldini G, Sargiacomo M, Lodish HF (1994) Induction of caveolin during adipogenesis and as sociation of GLUT4 with caveolin-rich vesicles. J Cell Biol 127:1233-1243
40. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP (1996) Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 93:131-135
41. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippo-campal neurons. Proc Natl Acad Sci USA 95:6460-6464
42. Smart EJ, Ying YS, Mineo C, Anderson RGW (1995) A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 92: 10104-10108
43. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP (1996a) Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains: detergent free purification of caveolae microdomains. J Biol Chem 271:9690-9697
44. Jong KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, et al. (1996b) Expression of caveolin-3 in skeletal, cardiac and smooth muscle cells: caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271: 15160-15165
45. Tang ZL, Okamoto T, Boontrakulpoontawee P, Katada T, Otsuka AJ, Lisanti MP (1997) Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans: implications for the molecular evolution of mammalian caveolin genes. J Biol Chem 272:2437-2445
46. Tang ZL, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, et al. (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271:2255-2261
47. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers M, Ishikawa Y (1998) Caveolin is an activator of insulin receptor signaling. J Biol Chem 273:26962-26968
48. Yang CP, Galbiati F, Volonté D, Horwitz SB, Lisanti MP (1998a) Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett 439:368-372
49. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, NasuY, et al. (1998b) Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 4:1873-1880